Subcategory
Other indications (e.g. myeloproliferative diseases), Myelodysplastic Syndrome (MDS)
Trial Type
other systemic therapies
Description for experts
Longitudinal, App-based Assessment of Varying Red Blood Cell Transfusion Strategies and their Association with Patient-Reported and Clinical Outcomes in Lower-Risk MDS Patients
Description for laymen
Longitudinal, App-based Assessment of Varying Red Blood Cell Transfusion Strategies and their Association with Patient-Reported and Clinical Outcomes in Lower-Risk MDS Patients
JSON Data
{
"short_title": "PRO-RED Studie",
"data_mode": "910",
"data_mode_number": "000000038",
"official_title": null,
"accrual_state": "running",
"therapeutic_value": "not_applicable",
"therapieansatz_value": "not_applicable",
"therapieintervention_value": "not_applicable",
"therapielinie_value": "not_applicable",
"ctgov_number": null,
"eudract_number": null,
"general_contact_email": "sal-aml-register@ukdd.de",
"general_contact_phone": "+49 351-45818380",
"hauptpruefer_dd_name": null,
"description_laie_de": "L\u00e4ngsschnitt und App-basierte Erfassung von Bluttransfusionsstrategien und deren Zusammenhang mit Lebensqualit\u00e4t und klinischem Verlauf bei Patienten mit Niedrigrisiko-MDS.",
"description_laie_en": "Longitudinal, App-based Assessment of Varying Red Blood Cell Transfusion Strategies and their Association with Patient-Reported and Clinical Outcomes in Lower-Risk MDS Patients",
"description_expert_de": "L\u00e4ngsschnitt und App-basierte Erfassung von Bluttransfusionsstrategien und deren Zusammenhang mit Lebensqualit\u00e4t und klinischem Verlauf bei Patienten mit Niedrigrisiko-MDS.",
"description_expert_en": "Longitudinal, App-based Assessment of Varying Red Blood Cell Transfusion Strategies and their Association with Patient-Reported and Clinical Outcomes in Lower-Risk MDS Patients",
"rechtsgrundlage_value": null,
"phase_amg_value": null,
"main_cat_id": 4,
"sub_cat_id": 25
}
